OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
317860.KN56

NordMason Co Ltd

Personal ProductsVerified

NordMason’s capital structure is highly leveraged, with a debt-to-equity ratio of 6.51, indicating significant reliance on debt financing. The company’s liquidity position is weak, as evidenced by a current ratio of 0.38 and negative free cash flow of -3.42 billion KRW. The negative operating cash flow of -844.76 million KRW and a cash balance of only 60.54 million KRW further highlight the company’s liquidity constraints. Profitability metrics are sharply negative, with a return on equity of -155.26% and a return on assets of -16.47%. These figures fall well below the typical performance of the Personal Products industry, which generally expects positive returns and healthy gross margins. NordMason’s operating loss of 2.43 billion KRW and net loss of 3.42 billion KRW underscore the company’s inability to generate sustainable earnings. The company’s revenue is derived from skincare and color cosmetics, with no disclosed segment breakdown. While NordMason operates in both domestic and overseas markets, the financial data does not provide geographic revenue distribution. This lack of transparency limits the ability to assess regional exposure and diversification. NordMason’s growth trajectory is uncertain, with no disclosed revenue growth or outlook for the current or next fiscal year. The company’s negative operating and net income, combined with a net loss, suggest a challenging operating environment. The absence of positive revenue momentum or clear growth drivers raises concerns about the company’s ability to reverse its financial performance. The company faces significant financial risk, with a medium liquidity risk and a negative net cash position after subtracting total debt. The risk assessment indicates a low dilution potential, but the company’s high debt load and negative cash flows suggest a potential need for capital raising in the near term. The absence of a clear capital preservation strategy increases the risk of further financial deterioration. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the financial snapshot indicates a deteriorating financial position, with declining profitability and liquidity. The company’s ability to address these issues will be critical to its long-term viability.

30-day price · 317860.KN-165.00 (-3.9%)
Low$4000.00High$4700.00Close$4025.00As of18 May, 00:00 UTC
Profile
CompanyNordMason Co Ltd
Ticker317860.KN
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. NordMason Co Ltd is a Korea-based company primarily engaged in the manufacture and sale of cosmetics, including skincare and color cosmetics, in domestic and overseas markets.

Classification. NordMason is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry, with a confidence level of 0.92.

NordMason’s capital structure is highly leveraged, with a debt-to-equity ratio of 6.51, indicating significant reliance on debt financing. The company’s liquidity position is weak, as evidenced by a current ratio of 0.38 and negative free cash flow of -3.42 billion KRW. The negative operating cash flow of -844.76 million KRW and a cash balance of only 60.54 million KRW further highlight the company’s liquidity constraints. Profitability metrics are sharply negative, with a return on equity of -155.26% and a return on assets of -16.47%. These figures fall well below the typical performance of the Personal Products industry, which generally expects positive returns and healthy gross margins. NordMason’s operating loss of 2.43 billion KRW and net loss of 3.42 billion KRW underscore the company’s inability to generate sustainable earnings. The company’s revenue is derived from skincare and color cosmetics, with no disclosed segment breakdown. While NordMason operates in both domestic and overseas markets, the financial data does not provide geographic revenue distribution. This lack of transparency limits the ability to assess regional exposure and diversification. NordMason’s growth trajectory is uncertain, with no disclosed revenue growth or outlook for the current or next fiscal year. The company’s negative operating and net income, combined with a net loss, suggest a challenging operating environment. The absence of positive revenue momentum or clear growth drivers raises concerns about the company’s ability to reverse its financial performance. The company faces significant financial risk, with a medium liquidity risk and a negative net cash position after subtracting total debt. The risk assessment indicates a low dilution potential, but the company’s high debt load and negative cash flows suggest a potential need for capital raising in the near term. The absence of a clear capital preservation strategy increases the risk of further financial deterioration. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the financial snapshot indicates a deteriorating financial position, with declining profitability and liquidity. The company’s ability to address these issues will be critical to its long-term viability.
Key takeaways
  • NordMason is highly leveraged, with a debt-to-equity ratio of 6.51 and negative free cash flow.
  • The company is unprofitable, with a return on equity of -155.26% and a return on assets of -16.47%.
  • Liquidity is severely constrained, with a current ratio of 0.38 and negative operating cash flow.
  • Growth is uncertain, with no disclosed revenue growth or positive financial momentum.
  • The company faces significant financial risk, with a negative net cash position and high debt load.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$21.13B
Gross profit$11.18B
Operating income-$2.43B
Net income-$3.42B
R&D
SG&A
D&A
SBC
Operating cash flow-$844.8M
CapEx-$175.0M
Free cash flow-$3.42B
Total assets$20.79B
Total liabilities$18.58B
Total equity$2.20B
Cash & equivalents$60.5M
Long-term debt$14.35B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.20B
Net cash-$14.28B
Current ratio0.4
Debt/Equity6.5
ROA-16.5%
ROE-1.6%
Cash conversion25.0%
CapEx/Revenue-0.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric317860.KNActivity
Op margin-11.5%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin-16.2%10.5% medp25 10.5% · p75 10.5%bottom quartile
Gross margin52.9%60.1% medp25 60.1% · p75 60.1%bottom quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-0.8%-2.3% medp25 -4.4% · p75 -1.1%top quartile
Debt / equity651.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 21:12 UTC#ff5f2391
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 21:14 UTCJob: e8d4f974